News

Deal Announcements

Aerpio Therapeutics Books Series A Venture Capital

Tuesday, September 4, 2012 5:32:00 AM PDT | VentureDeal
   Cincinnati, Ohio  --  Biotechnology company Aerpio Therapeutics has garnered $27 million in its first round of institutional venture capital investment.

Aerpio is developing small molecules and monoclonal antibodies to treat vascular disease and enhance wound healing.

Investors were led by the Novartis BioVenture Fund.

The company said proceeds will support ongoing development of its candidate pipeline.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1